Feng Li
Impact in
- Pharmacology top 0.2%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Physiology top 0.5%
- Alzheimer's disease research and treatments
- Adipose Tissue and Metabolism
Papers in
- Pharmacology 52
- Pharmacogenetics and Drug Metabolism 30
- Drug-Induced Hepatotoxicity and Protection 14
- Co-authors
- Xiaochao MaGunnar K. GourasHuaxi XuPaul GreengardRobert R. FriisSusanne SaurerRobert StrangeArne Burkhardt
- Journals
- Drug Metabolism and Disposition (11 papers)Journal of Biological Chemistry (7 papers)Scientific Reports (7 papers)Nature Communications (6 papers)Biochemical Pharmacology (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Feng Li
318 papers receiving 10.5k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Pharmacology 945
- Physiology 2.1k
- Biological Psychiatry 177
- Molecular Biology 4.9k
- Endocrine and Autonomic Systems 417
Countries citing papers authored by Feng Li
This map shows the geographic impact of Feng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Li more than expected).
Fields of papers citing papers by Feng Li
This network shows the impact of papers produced by Feng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Li. The network helps show where Feng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 31 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 27 | |
| 12 | 2022 | 0 | |
| 13 | 2021 | 49 | |
| 14 | 2020 | 11 | |
| 15 | 2019 | 97 | |
| 16 | 2018 | 18 | |
| 17 | 2018 | 19 | |
| 18 | [The relationship between chronic periodontitis and the instability of carotid atherosclerotic plaque by serum level of MMP-9, MCP-1 and MMP-7]. | 2015 | 2 |
| 19 | 2013 | 28 | |
| 20 | Intraneuronal Alzheimer Aβ42 Accumulates in Multivesicular Bodies and Is Associated with Synaptic Pathology Hit paper breakdown → | 2002 | 583 |
About Feng Li
Feng Li is a scholar working on Pharmacology, Biological Psychiatry, Oncology, Molecular Biology and Toxicology, having authored 335 papers that have together received 10.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (30 papers), Drug Transport and Resistance Mechanisms (27 papers), Liver Disease Diagnosis and Treatment (18 papers), Endoplasmic Reticulum Stress and Disease (14 papers), Drug-Induced Hepatotoxicity and Protection (14 papers), Autophagy in Disease and Therapy (13 papers), Adipose Tissue and Metabolism (13 papers) and Metabolomics and Mass Spectrometry Studies (10 papers). The work is most often cited by research in Pharmacology (945 citations), Physiology (2.1k citations), Biological Psychiatry (177 citations), Molecular Biology (4.9k citations) and Endocrine and Autonomic Systems (417 citations). Feng Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiaochao Ma, Gunnar K. Gouras, Huaxi Xu, Paul Greengard, Robert R. Friis, Susanne Saurer, Robert Strange, Arne Burkhardt, Reisuke H. Takahashi and M. Flint Beal. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Biological Chemistry, Scientific Reports, Nature Communications and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.